There seems to be greater prevalence of androgen dysregulation in elite-level female athletes via polycystic ovarian syndrome (PCOS) [273–276], and in experimental settings, women show responsiveness to androgen supplementation in an age- and dose-dependent manner [277–280], supporting the hypothesis that androgens and AR play some role in modulating female body composition and muscle function. Here, AR is linked to polycystic ovary syndrome.